2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 75.951 | 73.461 | 67.319 | 42.498 | 40.665 | 31.828 | 27.439 | 24.898 | 30.106 | 83.924 |
Total Income - EUR | 75.955 | 73.577 | 69.255 | 54.223 | 47.598 | 44.732 | 33.363 | 26.368 | 35.056 | 91.945 |
Total Expenses - EUR | 71.291 | 65.232 | 78.824 | 57.787 | 45.936 | 35.002 | 29.962 | 26.095 | 30.786 | 79.063 |
Gross Profit/Loss - EUR | 4.664 | 8.345 | -9.569 | -3.565 | 1.662 | 9.730 | 3.401 | 272 | 4.271 | 12.881 |
Net Profit/Loss - EUR | 2.795 | 7.143 | -10.262 | -4.107 | 1.186 | 9.361 | 3.085 | 9 | 3.920 | 11.950 |
Employees | 7 | 8 | 8 | 6 | 4 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medivet Amn Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 17.179 | 14.048 | 11.064 | 8.175 | 6.363 | 4.951 | 5.136 | 8.086 | 8.125 | 45.323 |
Current Assets | 39.646 | 48.939 | 35.075 | 29.543 | 32.439 | 41.780 | 40.716 | 43.693 | 48.627 | 31.813 |
Inventories | 12.941 | 21.111 | 17.485 | 15.904 | 16.002 | 21.226 | 25.171 | 29.977 | 36.259 | 27.370 |
Receivables | 12.266 | 10.465 | 12.107 | 12.275 | 15.896 | 14.740 | 13.974 | 12.125 | 11.787 | 3.943 |
Cash | 14.438 | 17.363 | 5.483 | 1.364 | 541 | 5.814 | 1.571 | 1.591 | 581 | 500 |
Shareholders Funds | 42.562 | 49.935 | 34.476 | 30.211 | 30.792 | 39.878 | 41.308 | 40.174 | 44.219 | 12.483 |
Social Capital | 491 | 495 | 490 | 482 | 473 | 464 | 455 | 445 | 446 | 445 |
Debts | 14.262 | 13.052 | 11.663 | 7.506 | 8.010 | 6.854 | 4.544 | 11.605 | 12.534 | 64.653 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Medivet Amn Srl